XL TechGroup, Inc.
19 July 2006


Press Release                                                       19 July 2006

                               XL TechGroup, Inc.

                       ('XL TechGroup' or 'the Company')

                 Establishment of depository interest facility
                   to enable holding and settlement in CREST


XL TechGroup (AIM: XLT), the systematic architect and builder of an ongoing
stream of high value new companies, announces that it has established, in
conjunction with Computershare Investor Services PLC acting as depository 
('Depository'), a depository interest arrangement  to facilitate the holding of
interests, and settlement of trades, in its common stock (USU984051008) in
CREST, the UK's electronic settlement system.  The distribution and compliance
period under Regulations S of the US Securities Act expired with respect to the
Company's common stock on October 12, 2005.

As the shares in the Company's common stock are foreign securities, the shares
cannot be admitted to CREST directly; instead, CREST members may, if they wish,
transfer their shares to the Depository (see below) in exchange for the
Depository issuing to them an equivalent number of (paperless) depository
interests ('DIs') in CREST, each of which represent a share of common stock in
the Company.  The terms of issue of the DIs are set out in a declaration of
trust executed by the Depository which is referred to as the 'Deed Poll'.
Copies of the Deed Poll are available from the Depository.

Existing CREST members who wish to exchange their share certificates for DIs in
CREST should refer to the CREST operational bulletin issued on 12 June 2006 for
details as to how to effect this exchange.  Shareholders who are not CREST
members or who will not have access to CREST functionality but would like to
hold DIs in CREST should contact either CREST or Computershare for further
information.


                                    - Ends -


For further information:
 XL TechGroup Inc.
 Mark Mohler, Legal Counsel                                 Tel: +1 321 409 7400

 Computershare Investor Services                       Tel: +44 (0) 870 707 1478

XL TechGroup media enquiries:
 Abchurch Communications
 Heather Salmond / Gareth Mead                         Tel: +44 (0) 20 7398 7700
 [email protected]                       www.abchurch-group.com


NOTES TO EDITORS

About XL TechGroup

XL TechGroup identifies unmet market needs in the Biotech, Ecotech and Medtech
sectors and then systematically creates and develops successful disruptive
technology businesses to exploit these needs.  The Company has developed a
unique proven method to rapidly bring companies from inception to liquidity,
matching unexploited IP from a group of corporate and technology partners to the
identified unmet market need.  XL TechGroup employs its own predictive algorithm
to ensure the market will rapidly adopt the identified solution and then moves
to scale the company specifically created to exploit the opportunity.

Before forming XL TechGroup, the management team created substantial value for
shareholders over a twelve year period, successfully exiting six technology
businesses at an average market valuation of approximately US$500 million.

The listing of the first company created under the XL TechGroup banner, AgCert
International, continues to validate the systematic approach to value creation.

•    AgCert International was created by XL TechGroup in May 2002 and is a 
     global leader in the production and sale of agriculturally derived 
     greenhouse gas emission reductions, with business in Europe, Asia, North 
     America and South America.  AgCert was listed on the London Stock Exchange 
     in June 2005 and XL TechGroup maintains a 24.7% interest in AgCert.  
     www.agcert.com

The second and third companies in the new generation of XL TechGroup businesses
are:
     
•    TyraTech LLC, which was created by XL TechGroup in July 2004, is developing 
     a new class of insecticides utilizing all natural active ingredients.
     TyraTech is able to quickly evaluate natural ingredient combinations by
     utilizing a patent-pending high throughput chemoreceptor screening process 
     that accurately predicts effectiveness levels.  TyraTech's development is 
     progressing rapidly in both insecticidal and related human healthcare 
     applications. TyraTech, which is 66.7% owned by XL TechGroup, is continuing 
     discussions with companies in North America, Asia and Europe as well as 
     numerous national public health programs about the licensing and 
     distribution rights for its patent-pending formulations in relation to 
     natural insecticide and personal care products.  www.tyratech.com

•    DxTech LLC was created by XL TechGroup in July 2005, and is developing a 
     unique micro-fluidic platform that replaces essentially all biological 
     tests currently performed at reference laboratories with a fully-automated,
     point-of-care device.  This technology has applications in significantly
     lowering costs and increasing efficiency for major pharmaceutical companies 
     in their clinical trials, the provision of diagnostics in developing 
     countries and delivering a new revenue stream for doctors in the USA.  
     DxTech is currently 88% owned by XL TechGroup.  www.dxtech.com

XL TechGroup has a number of other opportunities already at an advanced stage in
its business creation pipeline, and expects to create one-to-two new companies
annually that can each achieve a liquidity event worth at least US$400 million
within four years from inception.

For further information, see www.xltechgroup.com




                      This information is provided by RNS
            The company news service from the London Stock Exchange